ARTICLE | Company News
Noven, Aventis, Novartis deal
April 9, 2001 7:00 AM UTC
Novogyne Pharmaceuticals, a joint venture between NOVN and NVS, received U.S. marketing rights to CombiPatch estradiol/norethindrone, a transdermal hormone replacement therapy, from AVE. AVE will rec...